Search

everythinglearnresearchcommunity

for

Search:↓

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

The compound 4c effectively inhibits the enzyme linked to hair loss.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Prescription tablets treat hirsutism, while over-the-counter foams treat hypertrichosis.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Cimetidine does not significantly reduce hair growth in hirsutism.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Different Hairless isoforms affect Vitamin D receptor activity in hair regulation, with one repressing and the other stimulating it.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.